Works matching IS 03057453 AND DT 2010 AND VI 65 AND IP suppl_4

Results: 8

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv17, doi. 10.1093/jac/dkq252

By:

Jones, Ronald N.;
Mendes, Rodrigo E.;
Sader, Helio S.

Publication type:

Article

The problem of complicated skin and skin structure infections: the need for new agents.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv3, doi. 10.1093/jac/dkq250

By:

Moellering Jr., Robert C.

Publication type:

Article

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv41, doi. 10.1093/jac/dkq254

By:

Corey, G. Ralph;
Wilcox, Mark H.;
Talbot, George H.;
Thye, Dirk;
Friedland, David;
Baculik, Tanya

Publication type:

Article

Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv33, doi. 10.1093/jac/dkq253

By:

Drusano, George L.

Publication type:

Article

Preface.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv1, doi. 10.1093/jac/dkq271

By:

Johnson, Alan P.;
Leibovici, Leonard

Publication type:

Article

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv9, doi. 10.1093/jac/dkq251

By:

Biek, Donald;
Critchley, Ian A.;
Riccobene, Todd A.;
Thye, Dirk A.

Publication type:

Article

Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv67, doi. 10.1093/jac/dkq256

By:

Corrado, Michael L.

Publication type:

Article

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv53, doi. 10.1093/jac/dkq255

By:

Wilcox, Mark H.;
Corey, G. Ralph;
Talbot, George H.;
Thye, Dirk;
Friedland, David;
Baculik, Tanya

Publication type:

Article